Page 108

UNOFFICIAL 1737-108 (A) Polycystic disease; (B) Medullary cystic disease; (C) Nephritis (including Alport's syndrome); (4) Hypertensive nephrosclerosis; (5) Metabolic: (A) Cystinosis; (B) Amyloid; (C) Gout; (6) Congenital: (A) Hyperplasia; (B) Horseshoe kidney; (7) Toxic: (A) Analgesic nephropathy; (B) Heavy metal poisoning; (8) Irreversible acute renal failure: (A) Cortical necrosis; (B) Acute tubular necrosis; and (9) Trauma.

(b) Conditions and limitations affecting kidney transplant include: (1) A living, related donor with major blood group (ABO) and human leukocyte group A (HLA) histocompatibility, or an appropriate

cadaveric kidney with major blood group (ABO) and human leukocyte group A (HLA) histocompatibility shall be available; (2) Patient shall be in a stable emotional state; (3) There is no active infection at the time of transplant; (4) There are no general medical contraindications to major surgery and anesthesia; (5) Patient has a normal lower urinary tract; (6) There are no other major systemic disease which would preclude successful recovery potential (such as cancer, polyarteritis,

systemic lupus erythematosis or heart, lung or liver disease); (7) Patient is evaluated by a qualified authority in Hawaii and renal transplant is recommended; (8) Informed consent shall be obtained from the patient or the patient's representative; and (9) Age limits five through fifty. [Eff 08/01/94 ] (Auth: HRS §346-14; 42 C.F.R. §431.10) (Imp: 42 C.F.R. §440.230; 42 U.S.C. §1396b(i))

§§17-1737-95 to 17-1737-99 (Reserved).